You can now read 10 articles in a month for free on Read as much as you want anywhere and anytime for just 99¢.

The Boston Globe


Radius Health seeking $55m to develop bone drug

Options include IPO, private investors, asset sale

CAMBRIDGE — A month after shelving plans for an initial public offering because of what it called volatile market conditions, Radius Health Inc. is weighing other ways to raise the roughly $55 million needed to take its experimental osteoporosis drug through the next stage of development.

While the nine-year-old biotech still may seek to go public, chief executive Michael S. Wyzga said he also has begun talking to private investors about a new round of financing and is considering selling part of the company to a larger firm.

Loading comments...

You have reached the limit of 10 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week